Showing results (131-140 of 315) with videos related to

Sort By:
Pageof 32
Gynecologic Oncology|July 1, 1984
Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervixM S Piver, J J Barlow, S B Lele, et al.
Obstetrics and Gynecology|May 1, 1980
Second-look laparoscopy prior to proposed second-look laparotomyM S Piver, S B Lele, J J Barlow, et al.
Obstetrics and Gynecology|February 20, 1998
Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancerG H Eltabbakh, M S Piver, N Natarajan, et al.
American Journal of Obstetrics and Gynecology|February 1, 1977
The value of pre-therapy peritoneoscopy in localized ovarian cancerM S Piver, R G Lopez, F Xynos, et al.
Cancer Biochemistry Biophysics|June 1, 1991
Characterization of glycoconjugates released in vitro by human ovarian carcinoma cells isolated from effusionsH J Allen, M Gamarra, M S Piver, et al.
Immunological Investigations|February 1, 1991
Antigenic studies on an enzymatically sialylated carbohydrate: NeuAc(alpha 2-3)Gal(beta 1-3)[GlcNAc(beta 1-6)]GalNAcD J Handley, K L Matta, M S Piver, et al.
Obstetrics and Gynecology|November 5, 1999
Laparoscopic surgery in obese womenG H Eltabbakh, M S Piver, R E Hempling, et al.
Oncology|January 1, 1978
Leo 1031 (NSC-134087) in gynecologic malignanciesS B Lele, M S Piver, J J Barlow, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1997
Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistryB A Werness, J S Jobe, R A DiCioccio, et al.
Pageof 32